Recovery of resistant enterococci during vancomycin prophylaxis. - Test2 - elhamkhani - TriplyDB

Recovery of resistant enterococci during vancomycin prophylaxis.

Recovery of resistant enterococci during vancomycin prophylaxis.

http://www.wikidata.org/entity/Q40193955

about

Enterococcus gallinarum endocarditis occurring on native heart valves The life and times of the Enterococcus Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium Characterization of glycopeptide-resistant enterococci from a Swiss hospital.Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.In vitro detection of enterococcal vancomycin resistance Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria.Resistance of enterococci to glycopeptides.Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance.In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873 Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci Characterization of glycopeptide-resistant enterococci from U.S. hospitals.Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA.High-level vancomycin-resistant enterococci causing hospital infections Detection of vancomycin-resistant enterococci in fecal samples by PCR.Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci?Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)Clinical implications of positive blood cultures.Resistance to vancomycin and teicoplanin: an emerging clinical problem.Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis.Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci.Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria Identification of Enterococcus species isolated from human infections by a conventional test scheme.Problems with the disk diffusion test for detection of vancomycin resistance in enterococci.Clinical and microbiologic characteristics of pediococci.Evaluation of MicroScan for identification of Enterococcus species.Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.Vancomycin susceptibility and identification of motile enterococci New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.Determination of 16S rRNA sequences of enterococci and application to species identification of nonmotile Enterococcus gallinarum isolates.Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256 Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228 Activity of glycopeptides against vancomycin-resistant gram-positive bacteria

P2860

Q24538860-C8085D23-DA5A-4141-B75C-AAE5B14353B5 Q24616875-3875F126-0051-4D31-86FE-454640425F85 Q24676626-3DE340F8-AAC8-4147-909F-BE3FEE3A39F6 Q28378393-10411AAE-5FD6-423B-A7D5-CDA6938F2FA9 Q33671926-7701F552-75B1-4A86-B629-AEB5DE49117A Q33756700-60F177ED-00A6-44B5-969E-AB7C35BD76CE Q33965352-40069EDA-CA03-4B97-8C1B-D23D9C37693A Q35255945-E6409FE9-CACC-47AF-B506-AC50B14486B9 Q35275414-FB0B661D-1618-444E-9949-18BF0E558BEC Q35276250-4795AE7E-1B6F-4B83-BDC8-A55C90C64A2F Q35284014-96445F7A-2B59-4D33-8D10-86937DBF7A44 Q35287295-C7F3C983-6812-4F0A-81EB-59E18C66349F Q35350299-013F6919-6A1E-435D-8E13-005D1657C5EF Q35807947-29DA1EF0-D0B8-4BB7-BC68-A86CE0536C4A Q35825738-BB4828F5-7937-424D-977C-CC42AE595FDF Q35885570-CAD24C8A-2AE2-4DF6-BD7F-E84ACDA2EEEC Q35899762-673DCF10-C138-4F3A-9316-902611A3830C Q36100961-EBE735AC-4448-47E5-BC07-1574C1604721 Q36473265-E0F6514C-244E-44C2-B899-65F07ECE5201 Q36546392-95473D99-ECC3-48A1-AA54-C74A3728AA43 Q36546820-57FF6A1D-3CF0-4F8F-BA4A-026B1CB7D097 Q36548061-6305FAAB-AA40-43C5-960F-AAA1EE0FDFCC Q36635540-ECD438C2-BA28-4439-BDE1-B8A81341DC38 Q36636341-4E881FC6-0D65-4561-9772-E87E558115EE Q36752594-83B18808-B529-46E5-844D-2E33D5A886AD Q36752727-C7EA41A1-63B7-4425-A586-07FB1A75F186 Q37114177-835E3278-3572-42DD-9433-F92542A6BECA Q37129380-62BEB30C-F1E8-41B7-B56A-D677CD148172 Q37171428-6F6621C9-C7FA-4703-9455-A2DBDDA31A24 Q37171448-29C9D411-8075-448D-A8D0-6DD80B56497D Q37180779-6DEDB339-9756-459A-BE59-8A8ADB6C1EBE Q37184950-A453D4F2-434B-4229-B5D7-1D9D199EC2DA Q37185650-C6C3EA12-D388-4E45-B108-3D7660FF75E1 Q37242426-611A7A56-3C6D-4655-889B-67589FCEF100 Q37244123-B043A743-B9C4-4A49-A2E1-0050DFDDD8E2 Q37247830-D4CAA5E5-2B37-4F44-BEAC-9F7958B6A2A4 Q39556307-09C7BD97-5699-43EB-8E6A-796261D545CD Q39814923-96B03B04-1A9C-4B1A-985B-A8DE579E8413 Q39815434-F772AA30-423A-4839-9BD4-825380A01E7E Q39819863-7694DE77-5631-4318-99F9-145EA1C47BBC

P2860

Recovery of resistant enterococci during vancomycin prophylaxis.

http://www.wikidata.org/entity/Q40193955

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

Recovery of resistant enterococci during vancomycin prophylaxis.

@en

type

label

Recovery of resistant enterococci during vancomycin prophylaxis.

@en

prefLabel

Recovery of resistant enterococci during vancomycin prophylaxis.

@en

P1433

Q40193955-BC7CD35C-9642-4CEC-ADC1-0EDF208B33FA

P1476

Q40193955-4F29AD10-B430-4BE3-9146-647C9827AEE5

P2093

Q40193955-3B10E634-F52F-4D4C-A2EF-74467A135012

Q40193955-9117CF43-9F22-427A-8006-C77356DF6568

Q40193955-A0A274E1-6B03-4871-9997-38E6F15D45DC

P2860

Q40193955-310A4295-84D3-4466-B705-C0894ABE5AEC

Q40193955-53DF2D23-C397-441F-9EB0-035EA4C0FCA8

Q40193955-6F3B7C1E-5CCB-421A-9E75-E7E8C6C22969

Q40193955-70F52801-AE6F-4506-A2EF-A1AE61E5A9A3

Q40193955-7D918D3A-B31F-4905-A0B7-DB0217FDEF36

Q40193955-96ACB3AB-4EC0-44BD-8E7A-271AEDB4A71D

Q40193955-99D78B1D-552A-4F43-A2CC-D1BF0BD0895D

Q40193955-B1B778B2-4538-4168-AF71-36720DEB4DD3

Q40193955-C1892677-C213-48D8-A9D8-753E1ACEA0A6

Q40193955-DAF75B91-388F-4720-894A-0E2370276CA0

P304

Q40193955-3581BCDB-A76B-4849-AF86-7D88D034D3A6

P31

Q40193955-4351E785-3451-4C53-B661-329287A9937D

P407

Q40193955-479F31FE-9AF5-44A7-87E1-6FD9C01734CB

P433

Q40193955-27E82E85-8267-4D4F-8773-F690B2D07560

P478

Q40193955-901D6AD3-C18F-4C3C-A9F8-60E8A8FFACBB

P577

Q40193955-DBA6F62A-88D4-4D91-9352-675B05A2882A

P698

Q40193955-2CE5F066-3C6B-41DC-98A8-417096334A55

P932

Q40193955-3ACB10F0-175B-4483-88EA-616EC5EC2578

P1433

Journal of Clinical Microbiology

P1476

Recovery of resistant enterococci during vancomycin prophylaxis.

@en

P2093

Facklam RR

http://www.w3.org/2001/XMLSchema#string

Gilligan PH

http://www.w3.org/2001/XMLSchema#string

Kaplan AH

http://www.w3.org/2001/XMLSchema#string

P2860

Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp

Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents

Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations.

In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri.

Susceptibilities of enterococci to twelve antibiotics.

Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.

Emergence of vancomycin resistance in coagulase-negative staphylococci.

Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.

P304

1216-1218

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

1988-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3384933

http://www.w3.org/2001/XMLSchema#string

P932

266565

http://www.w3.org/2001/XMLSchema#string